In short: roughly 3.5% to 7% of emergency department syncope patients experience a serious adverse event within 30 days, serious arrhythmias account for about 2% to 3%, and 30-day mortality is near 1% to 2% — but these figures shift dramatically with risk stratification.
The Question
Among patients presenting to the emergency department (ED) for syncope, what is the short-term (30-day) incidence of serious arrhythmias or major cardiovascular events that result in death or require urgent intervention?
The Short Answer
The 30-day incidence of a composite serious adverse event — bundling serious arrhythmias, myocardial infarction, structural heart disease, pulmonary embolism, hemorrhage, procedural interventions, and death — falls in the range of approximately 3.5% to 7%, depending on whether procedural interventions are counted and on the case mix of the cohort. Serious arrhythmias are the single most common serious cardiac etiology, occurring in roughly 2% to 3% of patients overall, and a substantial proportion are not apparent at the index ED evaluation.
Composite Serious Outcomes at 30 Days
The Canadian Syncope Risk Score (CSRS) program provides the most methodologically rigorous contemporary data. In the multicenter prospective validation across nine Canadian EDs (3,819 patients), the observed 30-day serious outcome rate was 3.64% (95% CI, 3.09%–4.28%), closely matching the model-predicted 3.17%. Pooled across the CSRS derivation and validation cohorts (8,176 patients in whom no serious condition was identified at the index evaluation), 3.6% suffered a 30-day serious outcome after ED disposition.
The international validation of the CSRS, conducted across eight countries on three continents (2,283 patients aged ≥40 years), reported a higher composite rate: the primary composite outcome (serious clinical plus procedural events) occurred in 7.2% at 30 days, while the composite excluding procedural interventions occurred in 3.1%. This difference is clinically important — roughly half of the "serious outcome" burden in some cohorts reflects procedural interventions rather than spontaneous clinical events.
Serious Arrhythmias Specifically
Serious arrhythmias are the dominant serious cardiac cause and the principal driver of concern for occult, delayed events. Across the literature, approximately 2% to 3% of ED syncope patients suffer arrhythmia or death from an unknown (presumed arrhythmic) cause within 30 days of disposition. In the Canadian Syncope Arrhythmia Risk Score (CSARS) derivation cohort of 5,010 patients, 106 patients (2.1%) suffered 30-day arrhythmia or death after ED disposition.
Incidence by Risk Category
| CSRS Risk Category | Any Serious 30-Day Outcome | Arrhythmia Incidence |
|---|---|---|
| Very low / Low | ~0.3–0.7% | Negligible (no ventricular arrhythmias or deaths) |
| Medium | Intermediate | 4.9% |
| High | Up to ~51% | 18.0% |
Mortality
Thirty-day all-cause mortality in unselected ED syncope populations is low, on the order of 1% to 2%; a frequently cited meta-analytic estimate is approximately 1.6%. Mortality is strongly disposition-dependent: one cohort reported 1.8% mortality among discharged patients versus 14.7% among admitted patients, reflecting the substantially higher comorbidity and cardiovascular burden of admitted patients.
Timing & the Problem of Occult Arrhythmia
A defining clinical challenge is that one-third to one-half of serious conditions — particularly arrhythmias — are identified only after ED disposition. Of the serious conditions detected after disposition, roughly 69% are arrhythmias. The temporal pattern differs by mechanism: non-arrhythmic serious conditions tend to declare themselves within the first few days, whereas arrhythmias may be identified up to two weeks after the index ED visit. This distribution is the principal rationale for prolonged outpatient cardiac monitoring (15–30 days) in selected higher-risk patients.
Clinical Bottom Line
An aggregate 30-day serious outcome rate of ~3.5–7% is modest but clinically significant, because the events are potentially fatal and frequently occult at presentation. Validated risk stratification (e.g., CSRS) should guide disposition rather than reflexive admission: low- and very-low-risk patients can generally be discharged safely, while medium- and high-risk patients warrant consideration of prolonged outpatient rhythm monitoring.
References
- Thiruganasambandamoorthy V, Kwong K, Wells GA, et al. Development of the Canadian Syncope Risk Score to predict serious adverse events after emergency department assessment of syncope. CMAJ. 2016;188(12):E289–E298. PMID: 27378464.
- Thiruganasambandamoorthy V, Sivilotti MLA, Le Sage N, et al. Multicenter Emergency Department Validation of the Canadian Syncope Risk Score. JAMA Intern Med. 2020;180(5):737–744. PMID: 32202605.
- du Fay de Lavallaz J, Badertscher P, Nestelberger T, et al. International Validation of the Canadian Syncope Risk Score: A Cohort Study. Ann Intern Med. 2022;175(6):783–794.
- Thiruganasambandamoorthy V, Stiell IG, Sivilotti MLA, et al. Predicting Short-term Risk of Arrhythmia among Patients With Syncope: The Canadian Syncope Arrhythmia Risk Score. Acad Emerg Med. 2017;24(11):1315–1326.
- Thiruganasambandamoorthy V, Rowe BH, Sivilotti MLA, et al. Duration of Electrocardiographic Monitoring of Emergency Department Patients With Syncope. Circulation. 2019;139(11):1396–1406. PMID: 30661373.